{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T10:23:19Z","timestamp":1781173399546,"version":"3.54.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:00:00Z","timestamp":1769212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-12661-8","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T08:15:11Z","timestamp":1769242511000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Usefulness of the combined IFN-\u03b3 and IL-2 release test in distinguishing between pulmonary tuberculosis and non-pulmonary tuberculosis"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-4227-5439","authenticated-orcid":false,"given":"Wei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,24]]},"reference":[{"key":"12661_CR1","unstructured":"World health organization. Global tuberculaosis report. 2024. Available online at: https:\/\/www.who.int\/zh\/publications\/m\/item\/top-findings-and-messages-in-the-2024-report."},{"issue":"13","key":"12661_CR2","doi-asserted-by":"publisher","first-page":"274","DOI":"10.46234\/ccdcw2021.071","volume":"3","author":"X Du","year":"2021","unstructured":"Du X, Li T, Liu X, et al. Health facilities and treatment service models of the National tuberculosis Program - China, 2010\u20132020. China CDC Wkly. 2021;3(13):274\u20138.","journal-title":"China CDC Wkly"},{"issue":"7","key":"12661_CR3","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.cmi.2020.12.031","volume":"27","author":"L Zhang","year":"2021","unstructured":"Zhang L, Weng TP, Wang HY, et al. Patient pathway analysis of tuberculosis diagnostic delay: a multicentre retrospective cohort study in China. Clin Microbiol Infect. 2021;27(7):1000\u20136.","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"12661_CR4","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2169\/internalmedicine.47.0389","volume":"47","author":"K Yoshihiro Kobashi","year":"2008","unstructured":"Yoshihiro Kobashi K, Mouri S, Yagi, et al. Usefulness of the quantiferon TB-2G test for the differential diagnosis of pulmonary tuberculosis. Intern Med. 2008;47(4):237\u201343.","journal-title":"Intern Med"},{"issue":"10","key":"12661_CR5","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.2169\/internalmedicine.51.5703","volume":"51","author":"M Yoshihiro Kobashi","year":"2012","unstructured":"Yoshihiro Kobashi M, Abe K, Mouri, et al. Usefulness of tuberculin skin test and three interferon-gamma release assays for the differential diagnosis of pulmonary tuberculosis. Intern Med. 2012;51(10):1199\u2013205.","journal-title":"Intern Med"},{"issue":"6","key":"12661_CR6","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1053\/j.semdp.2017.06.003","volume":"34","author":"D Jain","year":"2017","unstructured":"Jain D, Ghosh S, Teixeira L, Mukhopadhyay S. Pathology of pulmonary tuberculosis and non-tuberculous mycobacterial lung disease: Facts, misconceptions, and practical tips for pathologists. Semin Diagn Pathol. 2017;34(6):518\u201329.","journal-title":"Semin Diagn Pathol"},{"issue":"4S","key":"12661_CR7","doi-asserted-by":"publisher","first-page":"S86","DOI":"10.1016\/j.ijtb.2020.09.025","volume":"67","author":"KK Chopra","year":"2020","unstructured":"Chopra KK, Singh Shweta. Tuberculosis: newer diagnostic tests: applications and limitations. Indian J Tuberc. 2020;67(4S):S86\u201390.","journal-title":"Indian J Tuberc"},{"issue":"4","key":"12661_CR8","first-page":"79","volume":"29","author":"J Duan","year":"2014","unstructured":"Duan J, Wang Y, Yuan H, et al. Comparison of Mycobacterium tuberculosis in five kinds of laboratory tests. J Mod Lab Med. 2014;29(4):79\u201382.","journal-title":"J Mod Lab Med"},{"issue":"1","key":"12661_CR9","doi-asserted-by":"publisher","first-page":"e24154","DOI":"10.1002\/jcla.24154","volume":"36","author":"WJ Bai","year":"2021","unstructured":"Bai WJ, Liu LL, Wu LP, et al. Assessing the utility of the Xpert Mycobacterium tuberculosis\/ Rifampin assay for analysis of Bronchoalveolar lavage fluid in patients with suspected pulmonary tuberculosis. J Clin Lab Anal. 2021;36(1):e24154.","journal-title":"J Clin Lab Anal"},{"issue":"4","key":"12661_CR10","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.jinf.2020.08.004","volume":"81","author":"CL Shi","year":"2020","unstructured":"Shi CL, Han P, Tang PJ, et al. Clinical metagenomic sequencing for diagnosis of pulmonary tuberculosis. J Infect. 2020;81(4):567\u201374.","journal-title":"J Infect"},{"key":"12661_CR11","doi-asserted-by":"publisher","first-page":"1224993","DOI":"10.3389\/fpubh.2023.1224993","volume":"11","author":"YL Li","year":"2023","unstructured":"Li YL, Bian WT, Wu SP, et al. Metagenomic next-generation sequencing for Mycobacterium tuberculosis complex detection: a meta analysis. Front Public Health. 2023;11:1224993.","journal-title":"Front Public Health"},{"issue":"5","key":"12661_CR12","first-page":"446","volume":"45","author":"SS Li","year":"2023","unstructured":"Li SS, Wang YF, Shu W, et al. Progress and reflections on development of laboratory diagnostic technology for tuberculosis. Clin J Antituberc. 2023;45(5):446\u201353.","journal-title":"Clin J Antituberc"},{"key":"12661_CR13","doi-asserted-by":"publisher","first-page":"571230","DOI":"10.3389\/fcimb.2020.571230","volume":"10","author":"C Yang","year":"2021","unstructured":"Yang C, Luo X, Fan L, et al. Performance of interferon-gamma release assays in the diagnosis of nontuberculous mycobacterial diseases-a retrospective survey from 2011 to 2019. Front Cell Infect Microbiol. 2021;10:571230.","journal-title":"Front Cell Infect Microbiol"},{"issue":"6","key":"12661_CR14","doi-asserted-by":"publisher","first-page":"300060520925660","DOI":"10.1177\/0300060520925660","volume":"48","author":"DF Lv","year":"2020","unstructured":"Lv DF, Liu YQ, Guo F, et al. Combining interferon-\u03b3 release assays with lymphocyte enumeration for diagnosis of Mycobacterium tuberculosis infection. J Int Med Res. 2020;48(6):300060520925660.","journal-title":"J Int Med Res"},{"issue":"12","key":"12661_CR15","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.3390\/pathogens13121050","volume":"13","author":"L Peng","year":"2024","unstructured":"Peng L, Ma WJ, Yang JR, et al. Diagnostic accuracy of Mycobacterium tuberculosis Antigen-Based skin tests (TBSTs) for tuberculosis infection compared with TST and igras: A network Meta-Analysis. Pathogens. 2024;13(12):1050.","journal-title":"Pathogens"},{"issue":"3","key":"12661_CR16","doi-asserted-by":"publisher","first-page":"e0192664","DOI":"10.1371\/journal.pone.0192664","volume":"13","author":"MPL Manna","year":"2018","unstructured":"Manna MPL, Orlando V, Li P. Identification of plasma biomarkers for discrimination between tuberculosis infection\/disease and pulmonary Non tuberculosis disease. PLoS ONE. 2018;13(3):e0192664.","journal-title":"PLoS ONE"},{"issue":"1","key":"12661_CR17","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12967-021-02970-8","volume":"19","author":"YJ Tan","year":"2021","unstructured":"Tan YJ, Tan YH, Li JL, et al. Combined IFN-\u03b3 and IL-2 release assay for detect active pulmonary tuberculosis: a prospective multicentre diagnostic study in China. J Transl Med. 2021;19(1):289.","journal-title":"J Transl Med"},{"issue":"1","key":"12661_CR18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.5411\/wji.v5.i1.16","volume":"5","author":"TB Romero-Adrian","year":"2015","unstructured":"Romero-Adrian TB, Leal-Montiel J, Fernardz G, et al. Role of cytokines and other factors involved in the Mycobacterium tuberculosis infection. World J Immunol. 2015;5(1):16\u201350.","journal-title":"World J Immunol"},{"issue":"7","key":"12661_CR19","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1086\/529049","volume":"197","author":"A Ajit Lalvani, Kerry","year":"2008","unstructured":"Ajit Lalvani, Kerry A, Millington. T cells and tuberculosis: beyond Interferon-\u03b3. J Infect Dis. 2008;197(7):941\u20133.","journal-title":"J Infect Dis"},{"issue":"6","key":"12661_CR20","first-page":"419","volume":"40","author":"The Tuberculosis Society of Chinese Medical Association, The Expert Consensus Writing Group for Pathological Diagnosis of Tuberculosis","year":"2017","unstructured":"The Tuberculosis Society of Chinese Medical Association, The Expert Consensus Writing Group for Pathological Diagnosis of Tuberculosis. Expert consensus on pathological diagnosis of tuberculosis in China. Chin J Tuberc Respir Dis. 2017;40(6):419\u201325.","journal-title":"Chin J Tuberc Respir Dis"},{"issue":"9","key":"12661_CR21","first-page":"688","volume":"41","author":"The Clinical Laboratory Professional Committee of the Tuberculosis Society of Chinese Medical Association","year":"2018","unstructured":"The Clinical Laboratory Professional Committee of the Tuberculosis Society of Chinese Medical Association. Expert consensus on molecular diagnosis of tuberculosis pathogens. Chin J Tuberc Respir Dis. 2018;41(9):688\u201395.","journal-title":"Chin J Tuberc Respir Dis"},{"issue":"6","key":"12661_CR22","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nri2274","volume":"8","author":"RA Seder","year":"2008","unstructured":"Seder RA, Darrah PA. T-cell quality in memory and protection:implications for vaccine design. Nat Rev Immunol. 2008;8(6):247\u201359.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"12661_CR23","first-page":"219","volume":"3","author":"HE Stefan","year":"2008","unstructured":"Stefan HE, et al. Tuberculosis in africa:learning from pathogenesis for biomarker identification. Cell Host\u0f06Microbe. 2008;3(4):219\u201328.","journal-title":"Cell Host\u0f06Microbe"},{"issue":"5","key":"12661_CR24","doi-asserted-by":"publisher","first-page":"e70010","DOI":"10.1002\/jcla.70010","volume":"39","author":"ZP Zhao","year":"2025","unstructured":"Zhao ZP, Li RQ, Zhao XY, et al. The diagnostic value of Interleukin-2 and Interferon-\u03b3 induced by fusion protein (EAST-6\/CFP-10\/Rv1985c) for active Mycobacterium tuberculosis infection. J Clin Lab Anal. 2025;39(5):e70010.","journal-title":"J Clin Lab Anal"},{"issue":"1","key":"12661_CR25","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1186\/s40001-025-02895-8","volume":"30","author":"JY Chen","year":"2025","unstructured":"Chen JY, Deng B, Li MY, et al. Analysis of the clinical value and influencing factors of combined detection of tuberculosis-specific cytokines IFN-\u03b3 and IL-2 in the diagnosis of active tuberculosis in children and adolescents. Eur J Med Res. 2025;30(1):732.","journal-title":"Eur J Med Res"},{"issue":"2","key":"12661_CR26","doi-asserted-by":"publisher","first-page":"308","DOI":"10.20411\/pai.v1i2.173","volume":"1","author":"C Lange","year":"2016","unstructured":"Lange C, Mandalakas AM, Kalsdorf B, et al. Clinical application of interferon-\u03b3 release assays for the prevention of tuberculosis in countries Witn low incidence. Pathog Immun. 2016;1(2):308\u201329.","journal-title":"Pathog Immun"},{"issue":"4","key":"12661_CR27","first-page":"343","volume":"45","author":"Society of clinical Microbiology and Infection of China International Exchange and Promotion Association for Medical and Healthcare, Clinical Microbiology Group of the Laboratory Medicine Society of the Chinese Medical Association, Clinical Microbiology Group of Microbiology and Immunology Society of the Chinese Medical Association","year":"2022","unstructured":"Society of clinical Microbiology and Infection of China International Exchange and Promotion Association for Medical and Healthcare, Clinical Microbiology Group of the Laboratory Medicine Society of the Chinese Medical Association, Clinical Microbiology Group of Microbiology and Immunology Society of the Chinese Medical Association. Chinese expert consensus on the best practice of Microbiological examination for Mycobacterium tuberculosis infection\/tuberculosis in general hospital. Chin J Lab Med. 2022;45(4):343\u201353.","journal-title":"Chin J Lab Med"},{"issue":"1","key":"12661_CR28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12879-018-3043-7","volume":"18","author":"MJ Donohue","year":"2018","unstructured":"Donohue MJ. Increasing nontuberculous mycobacteria reporting rates and species diversity identified in clinical laboratory reports. BMC Infect Dis. 2018;18(1):63\u20135.","journal-title":"BMC Infect Dis"},{"issue":"6","key":"12661_CR29","doi-asserted-by":"publisher","first-page":"e0197825","DOI":"10.1371\/journal.pone.0197825","volume":"13","author":"C Della Bella","year":"2018","unstructured":"Della Bella C, Spinicci M, et al. Novel M. tuberculosis specific IL-2 elispot assay discriminates adult patients with active or latent tuberculosis. PLoS ONE. 2018;13(6):e0197825.","journal-title":"PLoS ONE"},{"issue":"5","key":"12661_CR30","doi-asserted-by":"publisher","first-page":"e0177850","DOI":"10.1371\/journal.pone.0177850","volume":"12","author":"L Zhang","year":"2017","unstructured":"Zhang L, Cheng X, et al. Utility of Th1-cell immune responses for distinguishing active tuberculosis from non-active tuberculosis: A case- control study. PLoS ONE. 2017;12(5):e0177850.","journal-title":"PLoS ONE"},{"key":"12661_CR31","doi-asserted-by":"publisher","first-page":"102256","DOI":"10.1016\/j.tube.2022.102256","volume":"136","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Zhang FJ, Shi HL, et al. Host biomarkers other than interferon gamma in QFT-TB supernatants for identifying active tuberculosis. Tuberculosis. 2022;136:102256.","journal-title":"Tuberculosis"},{"issue":"4","key":"12661_CR32","doi-asserted-by":"publisher","first-page":"e0152483","DOI":"10.1371\/journal.pone.0152483","volume":"11","author":"S Maho","year":"2016","unstructured":"Maho S, Shunsuke A, et al. Combined analysis of IFN-\u03b3, IL-2, IL-5, IL-10, IL-1RA and MCP-1 in QFT supernatant is useful for distinguishing active tuberculosis from latent infection. PLoS ONE. 2016;11(4):e0152483.","journal-title":"PLoS ONE"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-12661-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12661-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12661-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T11:24:46Z","timestamp":1771327486000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-12661-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,24]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12661"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-12661-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,24]]},"assertion":[{"value":"18 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Fuyang People\u2019s Hospital (Ethical approval number: 2021(No.141). This study is a retrospective study that conducted anonymous analysis of past cases. Signing patient informed consent forms can be exempted because data collection, analysis, and article writing are all behaviors that expose patient privacy information. Multiple previous articles have done so.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Interpretation criteria (manufacturer\u2019s guidelines): Cytokine concentrations were calculated by subtracting values from negative control wells. Results were defined as follows: negative (IFN-\u03b3\u2009<\u20097 pg\/mL and IL-2\u2009<\u200920 pg\/mL), double-positive (IFN-\u03b3\u2009\u2265\u20097 pg\/mL and IL-2\u2009\u2265\u200920 pg\/mL), or single-positive (IFN-\u03b3\u2009\u2265\u20097 pg\/mL or IL-2\u2009\u2265\u200920 pg\/mL).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Supplement"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"379"}}